The management of patients on direct oral anticoagulants (DOACs) who require emergent cardiac surgery is slowly evolving. The introduction of andexanet alfa, a novel antidote for apixaban and rivaroxaban, added a specific reversal agent to our armamentarium, but its safety and efficacy are still being investigated. We report 2 patients on DOAC treatment who required emergency cardiac surgery. Both received perioperative andexanet alfa together with prothrombin complex concentrate (PCC) at some time during 6 hours before operative management. Heparin resistance was noted in each instance, and pump thrombosis developed in 1 case.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708075PMC
http://dx.doi.org/10.1213/XAA.0000000000001636DOI Listing

Publication Analysis

Top Keywords

andexanet alfa
12
prothrombin complex
8
complex concentrate
8
cardiac surgery
8
heparin insensitivity
4
insensitivity thrombotic
4
thrombotic risk
4
risk associated
4
associated sequential
4
sequential prothrombin
4

Similar Publications

Intracerebral hemorrhage (ICH) presents complex clinical challenges, particularly in patients receiving anticoagulation therapy. This case report discusses the management of acute ICH in a 60-year-old male patient on long-term apixaban therapy, who arrived at the emergency department with altered consciousness, right-sided hemiplegia, and mixed aphasia. Computed tomography (CT) imaging revealed a 70 ml left lenticular-capsular hematoma with significant mass effect, necessitating rapid intervention.

View Article and Find Full Text PDF
Article Synopsis
  • A 61-year-old man with a history of COPD, ongoing anticoagulant therapy, and pneumonia was admitted to the emergency department in critical condition due to chest pain and shortness of breath.
  • A chest X-ray and CT scan revealed a large mediastinal hematoma, rib fractures, and significant blood loss requiring urgent reversal of his anticoagulant medication before surgery.
  • After an emergency sternotomy to evacuate the hematoma, the patient made a full recovery, highlighting the importance of imaging in older patients with fall-related injuries and the need for careful management of anticoagulants.
View Article and Find Full Text PDF

Troubleshooting heparin resistance.

Hematology Am Soc Hematol Educ Program

December 2024

Departments of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC.

Article Synopsis
View Article and Find Full Text PDF

Background: The management of rivaroxaban overdose in severe traumatic brain injury (sTBI) is undocumented. Reversal with andexanet alfa (AA) and prothrombin complex concentrates (PCCs) in cases of supratherapeutic doses remains unproven. Management is further complicated by the absence of real-time serum rivaroxaban concentration assays and drug-specific coagulation assays.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!